University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering ...

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

Cheese addiction is real due to the presence of casein, a chemical that triggers the brain’s opioid receptors, similar to ...

Receptor.AI, a leading preclinical TechBio company transforming drug discovery through AI, has announced a new research ...

A new study shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less effective.

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

Whereas the postsynaptic antagonist actions of OPC-4392 are observed ... to provide a basis for understanding the unusual properties of this drug in the mammalian nervous system.

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.